V2T SUNSCREEN LIP BALM

Jeen International Corporation

Phase 
A
ProductINCISupplier%
Jeelux V2T1Isododecane, Triisostearyl Citrate, Bis-Vinyl Dimethicone/Dimethicone Copolymer 33.0
Jeecide® CAP-21Phenoxyethanol (and) Caprylyl Glycol (and) Hexylene glycol 0.5
Permethyl 99A2Isododecane 25.0
Permethyl 101A2Isohexadecane 8.2
Sunflower Wax1Sunflower Wax 3.0
Jeenate 5H1Polyethylene 10.0
B
ProductINCISupplier%
Sunscreen Active Ingredients:[Avobenzone: 9.4%; Homosalate: 47.2%; Octisalate: 15.7%, Octocrylene: 8.8%; Oxybenzone: 18.9%] 20.3

Preparation:
Mix phase A while increasing temperature to 80-85°C
Add phase B and mix until homogenous.
Pour at 80-85°C and chill.

Notes:
Suppliers
1 Jeen International 2 Presperse
While every effort has been made to reproduce these formulations correctly, the Publisher of this website cannot accept any liability for the information presented. All formulations are provided in good faith, but no warranty is given as to accuracy of information or results, or suitability for a particular use, nor is freedom from patent infringement to be inferred. Formulations are offered solely for consideration by the participating manufacurers. Continued use of this web site infers acceptance of this disclaimer.
Supplier Search
Article Search
Formulations Search

PRODUCT ARTICLE

A true petrolatum alternative
Until antibiotics conquered the world, the only possible method for curing gangrene was maggot therapy, except for amputation of the extremities. Maggots were applied to the wound and would eat the necrotic tissue, including the organisms that were responsible for that.

TECHNICAL ARTICLE

Skin defences boosted by grapefruit extract
Humans are constantly exposed to harmful foreign chemicals and materials from exogenous and endogenous sources. As a result, defence mechanisms have evolved to protect against toxin overload.1 Cells are under constant threat from metabolic waste products and xenobiotics. The formation of phase I and phase II metabolism mobilises and excretes these mainly lipophilic toxins.